Perlmutter Cancer Center

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Rms
• Age: Between 0 years - 40 years
• Gender: Male or Female

• Other Inclusion Criteria:
  

  1) Patients must have sufficient tissue available for the required biology study. 2) Adequate liver function. 3) Adequate bone marrow function.
  

You may not be eligible for this study if the following are true:

• 1) Patients who have previously received temsirolimus, another mTOR inhibitor, or any other investigational agent. 2) Patients who have received any chemotherapy (excluding steroids) and/or RT prior to this enrollment. 3) Patients with uncontrolled hyperglycemia and patients with uncontrolled hyperlipidemia. 4) Lactating females who plan to breastfeed their infants.